about
Low dose versus high dose stavudine for treating people with HIV infectionLow dose versus high dose stavudine for treating people with HIV infectionHuman cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistanceThe human mitochondrial deoxynucleotide carrier and its role in the toxicity of nucleoside antiviralsCloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2Accessory subunit of mitochondrial DNA polymerase from Drosophila embryos. Cloning, molecular analysis, and association in the native enzymeAssessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitorsAdverse effects of antiretroviral therapy for HIV infectionStructural and kinetic characterization of human deoxycytidine kinase variants able to phosphorylate 5-substituted deoxycytidine and thymidine analoguesHuman deoxycytidine kinase is located in the cell nucleusBench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitorsThe other genome: a systematic review of studies of mitochondrial DNA haplogroups and outcomes of HIV infection and antiretroviral therapyAntiviral activities and cellular toxicities of modified 2',3'-dideoxy-2',3'-didehydrocytidine analogues.Selective unfolding of one Ribonuclease H domain of HIV reverse transcriptase is linked to homodimer formationConformationally constrained nucleoside phosphonic acids--potent inhibitors of human mitochondrial and cytosolic 5'(3')-nucleotidasesFetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancyNovel ribofuranosylnucleoside lead compounds for potent and selective inhibitors of mitochondrial thymidine kinase-2Mitochondrial toxin 3-nitropropionic acid induces cardiac and neurotoxicity differentially in miceCardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudineCloning of mouse mitochondrial thymidine kinase 2 cDNAAnalysis and prediction of highly effective antiviral peptides based on random forestsCaenorhabditis elegans as a Model System for Studying Drug Induced Mitochondrial ToxicityHearing function in patients living with HIV/AIDS.Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians.A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.A mechanistic view of human mitochondrial DNA polymerase gamma: providing insight into drug toxicity and mitochondrial diseaseAntiretroviral therapy-induced mitochondrial toxicity: potential mechanisms beyond polymerase-γ inhibition.Azidothymidine-triphosphate impairs mitochondrial dynamics by disrupting the quality control system.Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitorsManagement of the adverse effects of antiretroviral therapy and medication adherence.Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.Aging and HIV/AIDS: pathogenetic role of therapeutic side effectsHuman immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals.Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs)Mitochondrial toxicity and HIV therapy.Mitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors.Safety of tenofovir during pregnancy for the mother and fetus: a systematic review.Gene therapy for the treatment of mitochondrial DNA disorders.Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs.
P2860
Q24186488-F69B2DDC-D66C-49E6-9BCD-281F35C2E09BQ24242088-99109F8C-166D-493F-8006-D695EBE67A34Q24290673-1E536F9B-6B12-4FEB-8788-F1D483DD340EQ24290877-E54646BC-AC8A-4B32-ABD2-EF1E77E91BB0Q24310289-577D9154-F21F-404F-B2D3-28764252E01FQ24321839-B0A35F19-7165-457A-95C1-31C922DF3E90Q24536268-0AB2BFD1-5646-4680-BB7C-FE3A4F94D764Q24617882-D6F12700-13F0-4D69-B5EE-8EC0330D53B5Q24629752-F50028DE-C211-4DDD-BEB8-2C2201D95840Q24647240-57E2DA0B-CFA4-488E-AE36-9C8DD42FFBE2Q24794857-25F19C62-D942-45D0-A6C8-BD65328E0944Q27027887-2798F99E-F7EE-4FB9-885F-03EDBE899057Q27472805-C1B0AE39-E5E7-43CD-A1AB-4DDD03B83A44Q27681926-B1B3F08E-C7E1-4E7D-AA29-C4060231B986Q27694878-9A8CEAA7-4FE2-4F7B-B72C-BDB89F9887A2Q28088783-5BC62600-4323-4C1E-99AD-E99CEAC96C6BQ28344795-17797790-55B8-4FE3-A668-E3F158621113Q28360954-C8C3EAB6-7C23-4D3E-B2A0-A19FE0DC1920Q28372167-38171D8B-4936-4F2B-8815-12CD1AC8D16AQ28504701-4FCE843D-7752-4A86-BD98-84B40572E9F1Q28535105-10C28B5B-2711-487B-9A65-68810E761636Q28547224-1D2F090B-AF3F-4DBE-A6D9-ED095E2BCE0FQ30399780-44A1E2D6-738E-42B6-8C5C-DC511F06821DQ31975873-55155C61-1233-4C4F-8390-D247362C77CFQ33609662-9FD49858-4AB6-4123-B35E-8292F14C93D0Q33749881-950A4722-18D6-4D27-97AD-F498BDFECF0FQ33756066-CE313E84-3D98-4D69-863A-B041DDADCCC1Q33784656-339E2A36-DFC1-470D-AABC-37A039CDC2E1Q33874792-CC314914-6A73-420E-BFEE-703E93C28A5DQ33904479-C9A2FE86-5A95-4C34-B160-CE3988879D22Q33946887-20919986-6874-4EAA-A894-156687EB218DQ33996797-8060FB1E-9B78-4689-B407-E7034BBFAE14Q34089694-E289B198-20FD-4E10-BCBF-2F095F2D10B2Q34196934-EE96A50C-8B37-4BA0-864E-7F49893979E4Q34200645-8D2ADF31-830C-40EA-BF5A-626BF88BE772Q34279271-68A8FA0B-8468-4608-B615-5CD401B4547AQ34282667-5170E82B-FB9F-4923-B1E9-FB4B114EC945Q34371989-0DE129B9-D261-4A4C-85D9-D21A7C24F888Q34401459-F6642B72-E80B-4EAF-A9CE-972D164F8AF8Q34423038-1C635146-CF4E-40D1-94FC-2FBD6981DAC4
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Mitochondrial toxicity of antiviral drugs.
@en
type
label
Mitochondrial toxicity of antiviral drugs.
@en
prefLabel
Mitochondrial toxicity of antiviral drugs.
@en
P2860
P356
P1433
P1476
Mitochondrial toxicity of antiviral drugs.
@en
P2093
P2860
P2888
P304
P356
10.1038/NM0595-417
P407
P577
1995-05-01T00:00:00Z